West Oak Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.9K | Sell |
9,193
-665
| -7% | -$193K | 1.03% | 37 |
|
|
2025
Q2 | $27.5K | Buy |
9,858
+1,335
| +16% | +$378K | 1.08% | 35 |
|
|
2025
Q1 | $26.6K | Sell |
8,523
-100
| -1% | -$29.5K | 1.03% | 28 |
|
|
2024
Q4 | $22.5M | Sell |
8,623
-200
| -2% | -$59.3K | 0.8% | 37 |
|
|
2024
Q3 | $28.4K | Sell |
8,823
-130
| -1% | -$42.5K | 0.53% | 27 |
|
|
2024
Q2 | $2.8M | Buy |
8,953
+417
| +5% | +$123K | 1.13% | 22 |
|
|
2024
Q1 | $2.43M | Buy |
8,536
+59
| +0.7% | +$17.3K | 1.03% | 30 |
|
|
2023
Q4 | $2.6M | Sell |
8,477
-255
| -3% | -$69.5K | 1.21% | 21 |
|
|
2023
Q3 | $2.35M | Buy |
8,732
+312
| +4% | +$77.9K | 1.17% | 24 |
|
|
2023
Q2 | $1.87M | Sell |
8,420
-555
| -6% | -$129K | 0.91% | 36 |
|
|
2023
Q1 | $2.17M | Buy |
8,975
+295
| +3% | +$72.4K | 1.1% | 28 |
|
|
2022
Q4 | $2.28M | Sell |
8,680
-385
| -4% | -$103K | 1.19% | 26 |
|
|
2022
Q3 | $2.04M | Sell |
9,065
-40
| -0.4% | -$9.7K | 1.11% | 29 |
|
|
2022
Q2 | $2.21M | Sell |
9,105
-247
| -3% | -$60.5K | 1.16% | 29 |
|
|
2022
Q1 | $2.26M | Buy |
9,352
+30
| +0.3% | +$6.89K | 1.02% | 34 |
|
|
2021
Q4 | $2.1M | Sell |
9,322
-95
| -1% | -$20.1K | 0.77% | 43 |
|
|
2021
Q3 | $2M | Buy |
9,417
+183
| +2% | +$42.1K | 0.78% | 45 |
|
|
2021
Q2 | $2.25M | Buy |
9,234
+185
| +2% | +$45.5K | 0.89% | 40 |
|
|
2021
Q1 | $2.25M | Buy |
9,049
+70
| +0.8% | +$16.7K | 0.96% | 37 |
|
|
2020
Q4 | $2.06M | Buy |
8,979
+400
| +5% | +$92.2K | 0.96% | 39 |
|
|
2020
Q3 | $2.18M | Sell |
8,579
-639
| -7% | -$158K | 1.2% | 27 |
|
|
2020
Q2 | $2.17M | Sell |
9,218
-225
| -2% | -$51.3K | 1.24% | 24 |
|
|
2020
Q1 | $1.91M | Buy |
9,443
+94
| +1% | +$20.5K | 1.31% | 23 |
|
|
2019
Q4 | $2.25M | Sell |
9,349
-1,043
| -10% | -$230K | 1.27% | 22 |
|
|
2019
Q3 | $2.01M | Sell |
10,392
-425
| -4% | -$81.6K | 1.18% | 34 |
|
|
2019
Q2 | $1.99M | Buy |
10,817
+770
| +8% | +$138K | 1.19% | 31 |
|
|
2019
Q1 | $1.91M | Buy |
10,047
+75
| +0.8% | +$14.3K | 1.19% | 31 |
|
|
2018
Q4 | $1.94M | Sell |
9,972
-8
| -0.1% | -$1.56K | 1.38% | 18 |
|
|
2018
Q3 | $2.07M | Buy |
9,980
+40
| +0.4% | +$7.88K | 1.2% | 22 |
|
|
2018
Q2 | $1.83M | Sell |
9,940
-3,925
| -28% | -$694K | 1.12% | 26 |
|
|
2018
Q1 | $2.36M | Buy |
13,865
+4,012
| +41% | +$736K | 1.4% | 11 |
|
|
2017
Q4 | $1.71M | Sell |
9,853
-170
| -2% | -$30.1K | 1.05% | 29 |
|
|
2017
Q3 | $1.87M | Sell |
10,023
-226
| -2% | -$40K | 1.11% | 23 |
|
|
2017
Q2 | $1.77M | Buy |
10,249
+22
| +0.2% | +$3.58K | 1.07% | 27 |
|
|
2017
Q1 | $1.68M | Buy |
10,227
+250
| +3% | +$41.5K | 1.03% | 33 |
|
|
2016
Q4 | $1.46M | Sell |
9,977
-285
| -3% | -$42.9K | 0.98% | 39 |
|
|
2016
Q3 | $1.71M | Buy |
10,262
+65
| +0.6% | +$11K | 1.18% | 25 |
|
|
2016
Q2 | $1.55M | Buy |
10,197
+115
| +1% | +$17.9K | 1.12% | 31 |
|
|
2016
Q1 | $1.51M | Sell |
10,082
-45
| -0.4% | -$6.69K | 1.16% | 28 |
|
|
2015
Q4 | $1.64M | Buy |
10,127
+735
| +8% | +$116K | 1.28% | 26 |
|
|
2015
Q3 | $1.3M | Buy |
9,392
+20
| +0.2% | +$3.15K | 1.05% | 35 |
|
|
2015
Q2 | $1.44M | Sell |
9,372
-500
| -5% | -$80.1K | 1.07% | 31 |
|
|
2015
Q1 | $1.58M | Sell |
9,872
-250
| -2% | -$39.4K | 1.16% | 28 |
|
|
2014
Q4 | $1.61M | Sell |
10,122
-1,140
| -10% | -$178K | 1.17% | 33 |
|
|
2014
Q3 | $1.58M | Sell |
11,262
-385
| -3% | -$50.3K | 1.18% | 28 |
|
|
2014
Q2 | $1.38M | Sell |
11,647
-120
| -1% | -$13.9K | 1% | 38 |
|
|
2014
Q1 | $1.45M | Sell |
11,767
-115
| -1% | -$13.9K | 1.06% | 36 |
|
|
2013
Q4 | $1.36M | Sell |
11,882
-30
| -0.3% | -$3.41K | 1% | 37 |
|
|
2013
Q3 | $1.33M | Sell |
11,912
-955
| -7% | -$104K | 1.04% | 34 |
|
|
2013
Q2 | $1.27M | Buy |
+12,867
| New | +$1.34M | 1.06% | 33 |
|
Other funds holding AMGN
West Oak Capital's AMGN Position: Q3 2025 in Review
West Oak Capital reduced its Amgen (AMGN) stake by 6.7% in Q3 2025, selling an estimated $193K and leaving 9,193 shares worth $25.9K. The position accounts for 1.03% of the portfolio, ranked #37.
West Oak Capital first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $22.5M in Q4 2024. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- West Oak Capital held 9,193 shares of Amgen worth $25.9K as of Q3 2025.
- West Oak Capital sold 665 Amgen shares in Q3 2025, an estimated $193K.
- Amgen made up 1.03% of West Oak Capital's portfolio in Q3 2025, its #37 holding.
- West Oak Capital first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
- West Oak Capital's Amgen position peaked at $22.5M in Q4 2024.
- 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on West Oak Capital's 13F filing for Q3 2025, filed 3 Oct 2025.